Choose Country & language

KARL STORZ and Well Lead Medical Announce Exclusive Agreement for Distribution of ClearPetra Stone-Removal System in the U.S.

02/05/2024 |

EL SEGUNDO, Calif.--()--KARL STORZ United States announces an exclusive agreement with Well Lead Medical to offer the ClearPetra suction-evacuation ureteral access sheath in conjunction with KARL STORZ endoscopic visualization devices for comprehensive urinary stone management.

 

The ClearPetra ureteral access sheath uses negative-pressure aspiration, enabling efficient and effective continuous-flow lithotripsy for stone removal.1 Now with a flexible tip, the sheath can be steered into the calyces within the kidney to remove renal stones.

ClearPetra signifies a breakthrough in urolithiasis treatment. This strategic collaboration aims to transform the landscape of endourology, enhancing patient care and surgical outcomes.

“Our strategic collaboration with Well Lead Medical on ClearPetra represents a major step forward in stone management. We are excited to provide this clinically differentiated technology, which is complementary to the range of solutions KARL STORZ offers urologists,” said Michael Hendershot, Vice President, Urology and Gynecology, Sales and Marketing at KARL STORZ United States.

“The collaboration between Well Lead Medical and KARL STORZ represents a significant milestone in our commitment to advancing endourology. The ClearPetra innovative technology, coupled with KARL STORZ's expertise in endoscopic solutions, will empower urologists to achieve superior surgical outcomes," said Duan Songfeng, Vice General Manager, International Sales & Marketing, Research Institute at Well Lead Medical.

 

MEDIA CONTACT:

Susan Mancia
Director, Integrated Marketing Communications
KARL STORZ United States
Phone: 562-841-1515